Certified by Founder Lodge 
                                        
                                        Orbital Therapeutics
 
                                                 United States  -  Cambridge, Massachusetts 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $270,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2022
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previousl
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| April, 27 ,2023 | Series A | $270,000,000 | 
                                                
 ARCH Venture Partners
                                                                                
 Alexandria Real Estate Equities, Inc.
                                                                                
 Exor Ventures
                                                                                
 Casdin Capital, LLC
                                                                                
 Thomas & Moore Strategic Ventures, LLC
                                                                                
                                                                            
 Invus Opportunities
                                                                                
 Agent Capital
                                                                                
 a16z Bio + Health
                                                                                
 Redmile Group
                                                                                
 Newpath Partners
                                                                                
 Abu Dhabi Growth Fund (ADG)
                                                                                
                                                                            
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)